Literature DB >> 23746017

Tantalum rod implantation and vascularized iliac grafting for osteonecrosis of the femoral head.

Dewei Zhao1, Yao Zhang, Weiming Wang, Yupeng Liu, Zhigang Li, Benjie Wang, Xiaobing Yu.   

Abstract

Osteonecrosis of the femoral head is a progressive disease. Without operative intervention, it most often results in collapse and deterioration of the joint. Many joint-preserving surgeries have been implemented, but no uniform treatment exists. The authors report a modified technique of tantalum rod implantation combined with vascularized iliac grafting for the treatment of osteonecrosis of the femoral head. Fifty-two patients (56 hips) with osteonecrosis of the femoral head (Association Research Circulation Osseous classification stage II-IV) treated with this technique were retrospectively reviewed. The major steps of this technique included vascularized iliac graft harvested, necrotic lesion excised, and combined interventions implantation. All patients were followed for a mean of 60 months. Seven hips had to be converted to a total hip arthroplasty. The 5-year joint-preserving success rate of entire group was 87.5%, with 95% for Association Research Circulation Osseous stage II hips, 92% for Association Research Circulation Osseous stage III hips, and 63.6% for Association Research Circulation Osseous stage IV hips. The success rate was lower for stage IV hips compared with stage II and III hips. Mean Harris Hip score of the 49 hips improved significantly from 50 to 91 points. Forty-three (76.8%) of 56 hips remained stable on radiographs. The technique of tantalum rod implantation combined with vascularized iliac grafting may be an effective joint-preserving method for the treatment of intermediate-stage osteonecrosis of the femoral head. A larger group of patients that is compared with a control group is necessary to further research. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23746017     DOI: 10.3928/01477447-20130523-26

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  21 in total

1.  What is the rate of patients undergoing a total hip arthroplasty after core decompression and insertion of a tantalum rod in osteonecrosis of the femoral head: a systematic review.

Authors:  Jean-Charles Aurégan; Benoît Villain; Thierry Bégué
Journal:  Int Orthop       Date:  2018-05-04       Impact factor: 3.075

2.  Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults.

Authors: 
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

3.  Early failures of porous tantalum osteonecrosis implants: a case series with retrieval analysis.

Authors:  Xianzuo Zhang; Jian Wang; Jun Xiao; Zhanjun Shi
Journal:  Int Orthop       Date:  2016-01-07       Impact factor: 3.075

4.  Modified porous tantalum rod technique for the treatment of femoral head osteonecrosis.

Authors:  Emilios E Pakos; Panayiotis Megas; Nikolaos K Paschos; Spyridon A Syggelos; Antonios Kouzelis; Georgios Georgiadis; Theodoros A Xenakis
Journal:  World J Orthop       Date:  2015-11-18

5.  Vascularized Iliac Bone Flap Transfer for Early and Middle Stages of Osteonecrosis of the Femoral Head.

Authors:  Dewei Zhao; Benjie Wang; Baoyi Liu
Journal:  JBJS Essent Surg Tech       Date:  2019-02-13

6.  Vascularized Greater Trochanter Bone Flap Transfer for Treatment of ARCO Stage-IIB to IIIB Osteonecrosis of the Femoral Head.

Authors:  Dewei Zhao; Baoyi Liu; Benjie Wang
Journal:  JBJS Essent Surg Tech       Date:  2019-06-12

7.  Outcome after a new porous tantalum rod implantation for treatment of early-stage femoral head osteonecrosis.

Authors:  Wei Huang; Xuan Gong; Steve Sandiford; Xiaoqiang He; Feilong Li; Yuwan Li; Ziming Liu; Leilei Qin; Jianye Yang; Sizheng Zhu; Jiawei Wang; Xiaolin Tu; Lei Ye; Ning Hu
Journal:  Ann Transl Med       Date:  2019-09

8.  Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head.

Authors:  Dewei Zhao; Baoyi Liu; Benjie Wang; Lei Yang; Hui Xie; Shibo Huang; Yao Zhang; Xiaowei Wei
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

Review 9.  The role of orthobiologics in hip preservation surgery.

Authors:  Zeiad Alshameeri; Andrew McCaskie
Journal:  J Hip Preserv Surg       Date:  2015-08-27

Review 10.  The Clinical Application of Porous Tantalum and Its New Development for Bone Tissue Engineering.

Authors:  Gan Huang; Shu-Ting Pan; Jia-Xuan Qiu
Journal:  Materials (Basel)       Date:  2021-05-18       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.